Ramiven 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Eli Lilly and Company India Pvt Ltd
  4. Ramiven 150 mg Tablet

Ramiven 150 mg Tablet

Ramiven 150 mg Tablet contains abemaciclib and is an oral anticancer medicine used for certain types of breast cancer. It works by blocking CDK4 and CDK6 proteins involved in the growth and division of cancer cells. The medicine is supplied as a prescription tablet and is marketed by Eli Lilly and Company India Pvt Ltd.

BUY NOW

Category

Abemaciclib helps control cancer cell growth by interfering with the cell cycle through inhibition of CDK4 and CDK6. It is used for appropriate patients with hormone receptor-positive and HER2-negative breast cancer, including advanced or metastatic disease. Ramiven 150 mg may be prescribed alone or with endocrine therapy depending on the patient’s treatment plan and clinical condition. Regular medical monitoring may be required during treatment to assess blood counts, liver function, and possible treatment-related adverse effects.

Technical Specification

Specification Details
Active Ingredient Abemaciclib
Strength 150 mg
Dosage Form Tablet
Therapeutic Class Anti-neoplastic
Storage Store below 30°C
Pack Size 7 tablets / 14 tablets

Product Also Known As

Ramiven 150 mg, Ramiven 150 mg Tablet, Abemaciclib 150 mg Tablet, Abemaciclib Tablets, Abemaciclib 150mg, CDK4/6 Inhibitor Tablet, Breast Cancer Medicine

Related products